503 KH-801, a differentated humanized anti-CD24 antibody, potentiates the effects of immunomodulatory and anti-tumor activity in preclinical cancer models with favorable safety profiles

流式细胞术 癌症研究 CD24型 单核细胞 体内 抗体 T细胞 化学 人性化鼠标 免疫系统 体外 免疫学 分子生物学 医学 生物 生物化学 CD44细胞 生物技术
作者
Ke Xiao,Yonghao Zhao,Pengfei Ren,Gang Lei,Menglong Guan,Pengfei Wu,Ju Yue,Jichao Wang,Yanhua Xu
出处
期刊: 卷期号:: A564-A566
标识
DOI:10.1136/jitc-2023-sitc2023.0503
摘要

Background

CD24 is a small GPI-anchored, highly glycosylated membrane protein, which interacting with Siglec-10 on TAMs (Tumor Associated Macrophages) acting as 'don't eat me' signals, and helping tumor cells avoid being engulfed by macrophages. CD24 is widely detected in many solid tumors.1 We have developed a unique humanized anti-CD24 antibody, KH-801, that depletes tumor cells not only by the Fc-mediated immune effector function, but also through blocking the CD24/Siglec10 axis signals in vivo and in vitro preclinical models.

Methods

Cell-based binding to human T cell, human B cell , human granulocyte and a panel of tumor cells was evaluated by flow cytometry. Mice M2 TAMs elimination and T cell infiltration in vivo were evaluated by flow cytometry after anatomy. The ability of KH-801 in enhancing phagocytosis of tumor cells was evaluated using human monocyte-derived M2 macrophage by live-cell microscopy and flow cytometry. in vivo efficacy of KH-801 was test in wild-type C57BL/6 and C57BL/6JSmoc-Siglecgtm1(hSIGLEC10)/Smoc bearing MC38 murine syngeneic colorectal cancer cells stable expressing human CD24. Toxicokinetics parameters of KH801 were evaluated in the one-month multiple-dose toxicity study in cynomolgus monkeys.

Results

KH-801 selectively binds to tumor cells compared to CD24 positive blood cells such as granulocytes, B cells and T cells, which may improve the therapeutic window of KH-801 in clinic (figure 1). KH-801 significantly promotes human monocyte-derived M2 macrophage phagocytosis of tumor cells with a single-digit nM activity. KH-801 Fc variant 2 without binding to FcγRs, still promote phagocytosis of Monocyte-derived M2 macrophages (figure 2). The results indicate that KH-801, a IgG1 isotype antibody, promotes phagocytosis of tumor cells not only through the Fc-mediated immune effector function, but also the blocking of CD24/Siglec10 axis signals. Besides, KH-801 promotes T cell infiltration into the tumor tissues and M2 TAMs elimination, that may transform cold tumors into hot tumors, and increase the anti-tumor potential for combination with other checkpoint inhibitors (figure 3). Moreover, dose-dependent anti-tumor efficacy has been demonstrated in multiple mouse tumor xenograft models (figure 4). Additionly, the differentiated epitope makes KH-801 exhibit good tolerance in monkey non-GLP toxicity studyv (table 1).

Conclusions

KH801 displays potent tumor growth inhibition activity through not only phagocytosis enhancement by blocking of CD24/Siglec10 axis signals, ADCC and ADCP to kill tumor cells directly, but also regulating tumor microenvironment by enhancing M2 TAMs elimination and T cell infiltration. The results show that KH-801 has potential treatment value in a variety of solid tumors.

References

Barkal AA, Brewer RE, Markovic M, Kowarsky M, Barkal SA, Zaro BW, Krishnan V, Hatakeyama J, Dorigo O, Barkal LJ, Weissman IL. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature. 2019 Aug;572(7769):392–396.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.2的应助被嘿嘿采纳,获得30
刚刚
吗喽完成签到,获得积分10
刚刚
feisun完成签到,获得积分10
刚刚
经常查查完成签到,获得积分10
刚刚
刘玲完成签到 ,获得积分10
1秒前
chenng完成签到,获得积分10
1秒前
陈陈完成签到,获得积分10
1秒前
2秒前
曾经的问枫完成签到,获得积分10
2秒前
绿豆百合周完成签到,获得积分10
2秒前
cyf完成签到,获得积分10
2秒前
Elsa发布了新的文献求助10
2秒前
大模型的应助被第五彧轩采纳,获得10
2秒前
薛定谔的猫完成签到,获得积分10
2秒前
吗喽发布了新的文献求助10
3秒前
3秒前
feisun发布了新的文献求助10
3秒前
Arina发布了新的文献求助10
3秒前
黄啦啦完成签到,获得积分10
5秒前
Tt发布了新的文献求助10
5秒前
幸运小鱼完成签到,获得积分10
5秒前
zhawenchang发布了新的文献求助10
6秒前
6秒前
Ava的应助被CC采纳,获得10
7秒前
大面包完成签到,获得积分10
7秒前
xxy完成签到,获得积分10
7秒前
上官若男的应助被大白采纳,获得10
8秒前
Owen的应助被可研小菜鸟采纳,获得10
8秒前
9秒前
chi2完成签到,获得积分10
9秒前
9秒前
fangzi完成签到,获得积分10
10秒前
10秒前
10秒前
yeo完成签到,获得积分10
11秒前
落寞的寒云完成签到,获得积分10
11秒前
TEXAS完成签到,获得积分10
11秒前
11秒前
bkagyin的应助被浅陌采纳,获得10
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8154161
求助须知:如何正确求助?哪些是违规求助? 9550701
关于积分的说明 21700590
捐赠科研通 7743260
什么是DOI,文献DOI怎么找? 3425651
关于科研通互助平台的介绍 2550861
邀请新用户注册赠送积分活动 2469363